DisperSol Appoints Tim Scott New President and CEO; Company Changes Name to AustinPx™, Pharmaceutics and ManufacturingBusiness Wire • 08/22/22
Catalent to Acquire Metrics Contract Services for $475 Million to Expand High-Potent Capabilities and Oral Development and Manufacturing CapacityBusiness Wire • 08/09/22
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2022 Earnings Conference WebcastBusiness Wire • 08/05/22
Catalent (CTLT) Up 0.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/02/22